[{"address1": "Maxim 1", "address2": "2 Parklands Way Holytown", "city": "Motherwell", "zip": "ML1 4WR", "country": "United Kingdom", "phone": "44 14 1433 7557", "website": "https://tcbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bryan Leland Kobel", "age": 45, "title": "CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 544560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin Edward Thorp", "age": 72, "title": "CFO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 410521, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Camarra", "title": "Executive Vice President of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lauren  Bor Ph.D.", "title": "Head of Commercial Development Division", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.95, "open": 1.88, "dayLow": 1.77, "dayHigh": 1.95, "regularMarketPreviousClose": 1.95, "regularMarketOpen": 1.88, "regularMarketDayLow": 1.77, "regularMarketDayHigh": 1.95, "payoutRatio": 0.0, "beta": 0.012, "forwardPE": -0.3869565, "volume": 162109, "regularMarketVolume": 162109, "averageVolume": 278113, "averageVolume10days": 378520, "averageDailyVolume10Day": 378520, "bid": 1.72, "ask": 1.91, "bidSize": 1, "askSize": 1, "marketCap": 913125, "fiftyTwoWeekLow": 1.7, "fiftyTwoWeekHigh": 523.2, "fiftyDayAverage": 5.92472, "twoHundredDayAverage": 67.3099, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 176698320, "profitMargins": 0.0, "floatShares": 98869384, "sharesOutstanding": 512992, "sharesShort": 128404, "sharesShortPriorMonth": 15913, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.25030002, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.0070499997, "shortRatio": 0.34, "shortPercentOfFloat": 0.2658, "impliedSharesOutstanding": 3195130, "bookValue": 81.056, "priceToBook": 0.021960126, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -11573336, "trailingEps": -4782.58, "forwardEps": -4.6, "lastSplitFactor": "1:20", "lastSplitDate": 1739145600, "enterpriseToEbitda": -15.599, "52WeekChange": -0.99287283, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 1.78, "targetHighPrice": 48.0, "targetLowPrice": 48.0, "targetMeanPrice": 48.0, "targetMedianPrice": 48.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1004329, "totalCashPerShare": 0.01, "ebitda": -11327400, "totalDebt": 1653527, "quickRatio": 0.642, "currentRatio": 1.12, "debtToEquity": 82.504, "returnOnAssets": -0.98203003, "returnOnEquity": -5.77043, "freeCashflow": -6030418, "operatingCashflow": -8837196, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "GBP", "symbol": "TCBP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "TC BioPharm (Holdings) plc", "longName": "TC Biopharm (Holdings) Plc", "regularMarketChangePercent": -8.717953, "regularMarketPrice": 1.78, "exchange": "NCM", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1741390724, "regularMarketTime": 1741381200, "messageBoardId": "finmb_1681274131", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644589800000, "postMarketChangePercent": 6.74157, "postMarketPrice": 1.9, "postMarketChange": 0.12, "regularMarketChange": -0.17000008, "regularMarketDayRange": "1.77 - 1.95", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 278113, "fiftyTwoWeekLowChange": 0.07999992, "fiftyTwoWeekLowChangePercent": 0.047058776, "fiftyTwoWeekRange": "1.7 - 523.2", "fiftyTwoWeekHighChange": -521.42, "fiftyTwoWeekHighChangePercent": -0.9965978, "fiftyTwoWeekChangePercent": -99.287285, "epsTrailingTwelveMonths": -4782.58, "epsForward": -4.6, "fiftyDayAverageChange": -4.14472, "fiftyDayAverageChangePercent": -0.6995639, "twoHundredDayAverageChange": -65.5299, "twoHundredDayAverageChangePercent": -0.97355515, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-11", "cryptoTradeable": false, "displayName": "TC Biopharm (Holdings)", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]